1st Edition
Nanoparticle Drug Delivery Systems for Cancer Treatment
In recent years, nanoparticles—bionanomaterials with specific physicochemical properties—have gained a great deal of scientific interest owing to their unique structure. Nanoparticle-based drugs are now widely regarded as a safer, more precise, and more effective mode of cancer therapy, considering their ability to enhance drug bioavailability, improve site-specific drug delivery, and protect nontarget tissues from toxic therapeutic drugs.
This book compiles and details cutting-edge research in nanomedicine from an interdisciplinary team of international cancer researchers who are currently revolutionizing drug delivery techniques through the development of nanomedicines and nanotheranostics. Edited by Hala Gali-Muhtasib and Racha Chouaib, two prominent cancer researchers, this book will appeal to anyone involved in nanotechnology, cancer therapy, or drug delivery research.
Nanoparticles as Drug Delivery Systems for Cancer Treatment: Applications in Targeted Therapy and Personalized Medicine
R. Chouaib et al.
Nanoparticles in Cancer Treatment: Types and Preparation Methods
J. Ahlawat et al.
The Role of Nanoparticles in Cancer Therapy through Apoptosis Induction
M. Rahmati et al.
Cell Membrane-Mimetic Nanoparticles for Cancer Treatment: What Has Been Done So far?
J. Basso et al.
Delivery of Immune Checkpoint Inhibitors Using Nanoparticles
A. Shaito and H. Hajj Hassan
A Perspective of Ultrasound Related Micro-/ Nano- Cancer Therapy
Z. Tingting et al.
Applications of Nanoparticles in the Treatment of Gliomas
G. Caruso et al.
Plant-Derived Edible Nanoparticles in Cancer Drug Delivery
S. Iravani et al.
Gold Nanoparticles as Promising Agents for Cancer Therapy
N. Karaki et al.
Anti-Tumor Activity of Verbascoside Loaded Noble Metal Nanoparticles
L. Yihai et al.
Structural Investigation of Bio-Synthesized Copper Nanoparticles Using Honey
R. Kale et al.
Biography
Hala Gali-Muhtasib is a tenured professor in the Department of Biology and director of the Center for Drug Discovery, American University of Beirut, Lebanon. She earned her PhD from Kansas State University, USA, and is a prominent scholar with outstanding contributions to the study of the role of natural and novel synthetic compounds in cancer therapy. She has published more than 100 research articles in peer-reviewed journals and is a recipient of five international/regional research awards for her contributions to anticancer drug therapy.
Racha Chouaib is a researcher at the Center for Drug Discovery, American University of Beirut, and assistant professor at the Lebanese International University and the Lebanese University. She received her PhD from the University of Montpellier, France, in 2016. She is a specialist in molecular genetics (RNA field) and has contributed to studies on the role of drug delivery systems in cancer therapy. She has published several research articles in peer-reviewed journals.
“This precious book provides a complete update to the most recent advances in the application and characterization of bionanomaterials in personalized medicine, including the molecular targeting of cancer. The authors have done a marvelous job. This reference is an exceptional source for scientists and students.” Prof. Hosam G. Abdelhady, Wayne State University, USA
“This book is a valuable research reference and an excellent addition to the library of any scientist working in the field of drug delivery for cancer treatment. It provides a comprehensive overview of nanomedicine and highlights the recent advances in their preparation, delivery strategies, assessment techniques, and specific clinical applications. The chapters explore the current state of the field and provide future perspectives and potential for clinical translation.” Dr. Ali Tehrani, American University of Beirut, Lebanon
“This timely collection contains cutting-edge research in the fields of nanoparticles, drug discovery, and cancer therapy, contributed by 10 international expert teams. It serves as a great reference for basic, translational, and clinical researchers.” Prof. Q. Ping Dou, Wayne State University, USA
